10x Genomics Reports Q2 Growth Amid Challenges
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
Leading genomics company, 10x Genomics, reported a 20% revenue growth in 2023 driven by the successful launch of their Xenium ...
© 2024 FinOracle.net - Your financial oracle, analytics and forecasts for stocks, cryptocurrency.